Brett Sandercock - 10 May 2021 Form 4 Insider Report for RESMED INC (RMD)

Role
Chief Financial Officer
Signature
Brett Sandercock, Chief Financial Officer
Issuer symbol
RMD
Transactions as of
10 May 2021
Transactions value $
-$490,000
Form type
4
Filing time
11 May 2021, 19:07:50 UTC
Next filing
14 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ResMed Common Stock Sale -$490K -2.5K -2.63% $196.00 92.5K 10 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction was conducted under a Rule 10b5-1 plan.
F2 Includes 80.54 shares of ResMed stock purchased on April 30, 2021, through the ResMed Employee Stock Purchase Plan.